Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
Abstract Cancer immunotherapy using immune-checkpoint inhibitors (ICIs) has revolutionized the field of cancer treatment; however, ICI efficacy is constrained by progressive dysfunction of CD8+ tumor-infiltrating lymphocytes (TILs), which is termed T cell exhaustion. This process is driven by divers...
Main Authors: | Dian Xiong, Lu Zhang, Zhi-Jun Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | Military Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40779-023-00496-2 |
Similar Items
-
Strategies to reinvigorate exhausted CD8+ T cells in tumor microenvironment
by: Qianting Guan, et al.
Published: (2023-06-01) -
Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
by: Jia‐Bin Wang, et al.
Published: (2023-05-01) -
Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades
by: Jun-Yan Li, et al.
Published: (2021-02-01) -
Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients
by: Chiara Camisaschi, et al.
Published: (2018-10-01) -
A ROS-responsive synergistic delivery system for combined immunotherapy and chemotherapy
by: Doudou Hu, et al.
Published: (2022-03-01)